IQV Iqvia Holdings PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: IQV
- PE Ratio
As of May 8, 2025, the Iqvia Holdings stock's PE ratio is 20.69. This takes into account the latest EPS of $7.41 and stock price of $153.29. The PE ratio marks a decrease of 23% from its last 4 quarters average of 26.9.
IQV PE ratio history
The PE ratio of Iqvia Holdings has averaged 165.94 over the last ten years. The current P/E ratio of 20.69 is 88% lower than the historical average. Looking back at the last ten years, IQV's PE ratio peaked in the Mar 2017 quarter at 4,026.5, when the price was $80.53 and the EPS was $0.02. The lowest point was in the Dec 2017 quarter, when it reached 16.71 with a price of $97.9 and an EPS of $5.86.
Iqvia Holdings PE ratio by year
Maximum annual increase: 626.79% in 2016
Maximum annual decrease: -89.45% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 25.96 | -17.09% | $196.51 | $7.57 |
| 2023 | 31.31 | -11.05% | $231.38 | $7.39 |
| 2022 | 35.2 | -37% | $204.89 | $5.82 |
| 2021 | 55.87 | -54.47% | $282.14 | $5.05 |
| 2020 | 122.72 | -22.16% | $179.17 | $1.46 |
| 2019 | 157.66 | 72.36% | $154.51 | $0.98 |
| 2018 | 91.47 | 447.4% | $116.17 | $1.27 |
| 2017 | 16.71 | -89.45% | $97.9 | $5.86 |
| 2016 | 158.44 | 626.79% | $76.05 | $0.48 |
| 2015 | 21.8 | 2.93% | $68.66 | $3.15 |
| 2014 | 21.18 | -16.35% | $58.87 | $2.78 |
| 2013 | 25.32 | N/A | $46.34 | $1.83 |
| 2012 | N/A | N/A | N/A | $1.53 |
| 2011 | N/A | N/A | N/A | $2.08 |
| 2010 | N/A | N/A | N/A | $1.38 |
Iqvia Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 23.79 | -8.36% | $176.3 | $7.41 |
| Dec 2024 | 25.96 | -15.55% | $196.51 | $7.57 |
| Sep 2024 | 30.74 | 13.39% | $236.97 | $7.71 |
| Jun 2024 | 27.11 | -20.45% | $211.44 | $7.8 |
| Mar 2024 | 34.08 | 8.85% | $252.89 | $7.42 |
| Dec 2023 | 31.31 | -3.57% | $231.38 | $7.39 |
| Sep 2023 | 32.47 | -14.49% | $196.75 | $6.06 |
| Jun 2023 | 37.97 | 8.24% | $224.77 | $5.92 |
| Mar 2023 | 35.08 | -0.34% | $198.89 | $5.67 |
| Dec 2022 | 35.2 | 21.63% | $204.89 | $5.82 |
| Sep 2022 | 28.94 | -18.64% | $181.14 | $6.26 |
| Jun 2022 | 35.57 | -13.07% | $216.99 | $6.1 |
| Mar 2022 | 40.92 | -26.76% | $231.21 | $5.65 |
| Dec 2021 | 55.87 | -6.71% | $282.14 | $5.05 |
| Sep 2021 | 59.89 | -21.65% | $239.54 | $4 |
IQV average PE ratio chart
IQV's current PE ratio is lower than its 3, 5 and 10-year averages.
IQV PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| IQV Iqvia Holdings Inc | 20.69 | $26.52B |
| NWBO Northwest Biotherapeutics Inc | N/A | $378.7M |
Frequently asked questions
What is Iqvia Holdings's PE ratio?
The price to earnings ratio for IQV stock as of May 8, 2025, stands at 20.69.
What is the 3-year average PE ratio for Iqvia Holdings (IQV)?
Over the last 3 years, the average price to earnings ratio for IQV stock is 31.52.
What is the 5-year average PE ratio for Iqvia Holdings (IQV)?
Over the last 5 years, the average price to earnings ratio for IQV stock is 59.97.
What is the highest PE ratio for IQV?
Over the last ten years, the Mar 2017 quarter recorded the highest quarterly PE ratio at 4,026.5.
How does the current PE ratio for IQV compare to its historical average?
IQV's price to earnings ratio is currently 88% below its 10-year historical average.
How is IQV's PE ratio calculated (Iqvia Holdings PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 8, 2025), Iqvia Holdings's share price is $153.29. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $7.41. Therefore, Iqvia Holdings's PE ratio for today is 20.69. PE RATIO(20.69) = STOCK PRICE($153.29) / TTM EPS($7.41)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.